EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

The Efficacy and Safety of Dotinurad on Uric Acid and Renal Function in Patients with Hyperuricemia and Advanced Chronic Kidney Disease: A Single Center, Retrospective Analysis

Katsunori Yanai, Keiji Hirai iD, Shohei Kaneko iD, Yuko Mutsuyoshi, Taisuke Kitano iD, Haruhisa Miyazawa, Kiyonori Ito, Yuichiro Ueda, Susumu Ookawara, Yoshiyuki Morishita

Drug Design, Development and Therapy · 2023-11 · Volume 17 · 3233-3248

DOI: 10.2147/dddt.s416025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2023-11. Verfasst von Katsunori Yanai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan. Hauptthemen laut MEDLINE: Hyperuricemia, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperuricemiaRenal Insufficiency, ChronicMaleHumansFemaleMiddle AgedAgedAged, 80 and overUric AcidRetrospective StudiesUricosuric AgentsGlomerular Filtration RateKidneyBenzothiazoles

Stichwörter der Autor:innen

chronic kidney diseasedotinuradhyperuricemiarenal functionuric acid

Substanzen

Uric AcidUricosuric AgentsdotinuradBenzothiazoles

Autor:innen und Institutionen

  • Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.

ORCID-Profile: Keiji Hirai, Shohei Kaneko, Taisuke Kitano

Zitieren

APA

Yanai, K., Hirai, K., Kaneko, S., Mutsuyoshi, Y., Kitano, T., Miyazawa, H., Ito, K., Ueda, Y., Ookawara, S., & Morishita, Y. (2023). The Efficacy and Safety of Dotinurad on Uric Acid and Renal Function in Patients with Hyperuricemia and Advanced Chronic Kidney Disease: A Single Center, Retrospective Analysis. Drug Design, Development and Therapy, Volume 17, 3233-3248. https://doi.org/10.2147/dddt.s416025

Vancouver

Yanai K, Hirai K, Kaneko S, Mutsuyoshi Y, Kitano T, Miyazawa H, et al. The Efficacy and Safety of Dotinurad on Uric Acid and Renal Function in Patients with Hyperuricemia and Advanced Chronic Kidney Disease: A Single Center, Retrospective Analysis. Drug Design, Development and Therapy. 2023;Volume 17:3233-3248. doi:10.2147/dddt.s416025

BibTeX
@article{Yanai2023,
  author = {Yanai, Katsunori and Hirai, Keiji and Kaneko, Shohei and Mutsuyoshi, Yuko and Kitano, Taisuke and Miyazawa, Haruhisa and Ito, Kiyonori and Ueda, Yuichiro and Ookawara, Susumu and Morishita, Yoshiyuki},
  title = {The Efficacy and Safety of Dotinurad on Uric Acid and Renal Function in Patients with Hyperuricemia and Advanced Chronic Kidney Disease: A Single Center, Retrospective Analysis},
  journal = {Drug Design, Development and Therapy},
  year = {2023},
  volume = {Volume 17},
  pages = {3233--3248},
  doi = {10.2147/dddt.s416025}
}
Kostenlos starten →